Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.86 EUR
Market Cap: 55.5m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Shedir Pharma Srl Unipersonale
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shedir Pharma Srl Unipersonale
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
Net Change in Cash
-€14.5m
CAGR 3-Years
N/A
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Net Change in Cash
€184k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Net Change in Cash
-€67.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Pierrel SpA
MIL:PRL
Net Change in Cash
€3.6m
CAGR 3-Years
N/A
CAGR 5-Years
34%
CAGR 10-Years
N/A
Friulchem SpA
MIL:FCM
Net Change in Cash
-€2.4m
CAGR 3-Years
-63%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.2m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.59 EUR
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Shedir Pharma Srl Unipersonale's Net Change in Cash?
Net Change in Cash
-14.5m EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Net Change in Cash amounts to -14.5m EUR.

What is Shedir Pharma Srl Unipersonale's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-39%

Over the last year, the Net Change in Cash growth was -340%.

Back to Top